DOCSLIB.ORG

Non-Neoplastic Skin Disease: a Practical Approach

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Non-Neoplastic Skin Disease: a Practical Approach Inflammatory Dermatopathology: A Survival Kit for Surgical Pathologists Steven D. Billings, MD Cleveland Clinic, Cleveland, OH [email protected] Inflammatory Dermatopathology • Difficult • Overlapping histologic features • Impenetrable terminology • Specific diagnosis often elusive Inflammatory Dermatopathology How to produce good reports • Diagnostic category • Tumor vs. rash? • Which inflammatory pattern? • Clinical presentation • Information regarding clinical features can influence histologic interpretation • Communication with clinicians crucial • Telephone 2nd most important tool 1 Ideal Dermatopathology Report • Microscopic description • Diagnosis • Specific diagnosis often not possible • Often ―descriptive‖ diagnosis • Example: ―Spongiotic dermatitis‖ • Note • Explain differential diagnosis • What diagnosis is favored • Additional comments as needed Pattern Recognition • Skin has limited ways to react • Predominant pattern of inflammatory infiltrate helps define diagnostic categories • Patterns can overlap • Some entities can have a variety of patterns General Concepts • Pattern recognition • Epidermal predominant vs. dermal predominant • Epidermal changes trump dermal changes • Distribution of the inflammatory infiltrate • Superficial vs. superficial and deep • Location: perivascular, interstitial, nodular • Nature of inflammatory infiltrate • Mononuclear (lymphocytes and histiocytes) • Mixed (mononuclear and granulocytes) • Granulocytic • Correlation with clinical presentation 2 Principle Patterns: Epidermal Changes Predominant • Spongiotic pattern • Psoriasiform pattern • Spongiotic and psoriasiform often co-exist • Interface pattern • Basal vacuolization • Perivascular infiltrate or • Lichenoid infiltrate Principle Patterns: Dermal Changes Predominant • Superficial perivascular • Superficial and deep perivascular • Interstitial pattern • Palisading granulomatous • Nodular and diffuse • Sclerosing pattern • Panniculitis • Bullous disease • Miscellaneous Spongiotic Dermatitis 3 Case A 40-year-old woman presented with linear blisters on both forearms. 4 Diagnosis: Spongiotic Dermatitis 5 Spongiotic Dermatitis • Three phases • Acute • Subacute • Chronic • Different but overlapping histologic features Spongiotic Dermatitis • Acute spongiotic dermatitis • Normal ―basket-weave‖ stratum corneum • Pale keratinocytes • Spongiosis • Spongiotic vesicles (variable) • Papillary dermal edema • Variable superficial perivascular infiltrate of lymphocytes often with some eosinophils 6 Spongiotic Dermatitis • Subacute spongiotic dermatitis • Parakeratosis • Diminished granular layer • Spongiosis • Acanthosis (overlap with psoriasiform pattern) • Variable superficial perivascular infiltrate of lymphocytes often with some eosinophils • Less edema 7 Spongiotic Dermatitis • Chronic spongiotic dermatitis • Hyperkeratosis • Parakeratosis • Irregular granular layer • Acanthosis (overlap with psoriasiform) • Minimal to mild spongiosis • Variable perivascular infiltrate • Dermis may be fibrotic 8 Common Clinical Types of Spongiotic Dermatitis • Eczema Dermatitis Family • Atopic dermatitis • Contact dermatitis • Nummular dermatitis • Dyshidrotic dermatitis (hand/foot dermatitis) • Id reaction (autoeczematization) • Eczematous drug eruption Eczema • Clinical term • Histologically spongiotic dermatitis • Specific diagnosis dependent on correlation with clinical presentation • CLINICAL SUBTYPES ARE HISTOLOGICALLY INDISTINGUISHABLE Atopic Dermatitis • Chronic pruritic, relapsing papular dermatitis • Associated with history of asthma, allergic rhinitis (atopy) • Predilection for flexural areas, especially in children 9 Allergic Contact Dermatitis • Clinical • Erythematous papules, plaques and sometimes vesicles • May have linear pattern • Secondary to type IV delayed hypersensitivity reaction • Examples: nickel allergy, poison ivy • Microscopic • Typical spongiotic dermatitis • May have Langerhans cell microabscesses 10 11 Irritant Contact Dermatitis • Clinical • Erythematous papules and vesicles • Secondary to direct irritant effect • Example: diaper rash • Microscopic • Typical spongiotic dermatitis • Ballooning degeneration of keratinocytes Nummular Dermatitis • Common form of eczema that is biopsied • Clinical • Pruritic round to oval patches and plaques • Often on extremities • Microscopic • Psoriasiform and spongiotic • Can be classified as psoriasiform dermatitis • Differential diagnosis • Psoriasis 12 Dyshidrotic Eczema (Pomphylox) Symmetric involvement of hands and/or feet Often vesicular Clinical and histologic differential diagnosis: vesicular dermatophyte infection 13 Id Reaction (Autoeczematization) • Widespread dissemination of previously localized ―eczematous‖ process • Triggers • Dermatophyte infection • Stasis dermatitis • Discontinuation of systemic steroids • Others • Abnormal immune response to skin antigens 14 Eczematous Drug Reaction Clinical • 5-10% of drug reactions may be eczematous in nature • Widespread eruption • Microscopic • Typical spongiotic dermatitis Practical Tips for Eczematous Dermatitis • Dx: ―spongiotic dermatitis, see note‖ • Dx in cases with acanthosis: ―spongiotic psoriasiform dermatitis, see note‖ • Note: ―The histologic features are compatible with an eczematous dermatitis. The DDx could include….. Clinicopathologic correlation is recommended.‖ • Tips • Eliminate where possible more specific entities • Neutrophils in stratum corneum or epidermis: exclude dermatophytosis or psoriasis • Clinical history can be helpful • Langerhans cell microabscess: suggest contact dermatitis Other Forms of Spongiotic Dermatitis • Vesicular dermatophytosis • Stasis dermatitis • Pityriasis rosea 15 Case 68 year-old woman with crusted, red scaly plaques on lower legs 16 Stasis Dermatitis • Clinical • Lower extremities associated with venous insufficiency • May develop ulcers • May clinically mimic a neoplasm (e.g. SCC) • Microscopic • Subacute to chronic spongiotic dermatitis • Significant acanthosis • Lobular proliferation of thick-walled dermal vessels • Extravasated erythrocytes, siderophages, perivascular lymphocytes • Variable dermal fibrosis 17 Stasis Dermatitis • Differential diagnosis • Eczematous dermatitis • Kaposi sarcoma • Tips • High index of suspicion • Vascular changes key feature 18 Case 29 year-old medical student with red scaly plaques on trunk 19 Pityriasis Rosea • Clinical • Affects young adults • Round to oval salmon-colored herald patch • Widespread, symmetric eruption on trunk . Microscopic • Subacute spongiotic dermatitis • Mounds of parakeratosis • Superficial perivascular mononuclear cell infiltrate • Extravasation of erythrocytes in papillary dermis 20 Pityriasis Rosea • Differential diagnosis • Eczematous dermatitis, guttate psoriasis • Tips: • Parakeratotic mounds key feature • Sign out descriptively in absence of good history • Dx: Spongiotic dermatitis • Note: Given the discrete mounds of parakeratosis, the histologic differential diagnosis would include pityriasis rosea. CPC recommended. Psoriasiform Dermatitis • Pattern often co-exists with spongiosis • Entities in psoriasiform dermatitis ddx • Psoriasis • Subacute to chronic spongiotic dermatitis • Stasis dermatitis • Lichen simplex chronicus/prurigo nodularis • Dermatophytosis • Pityriasis rubra pilaris Psoriasiform Dermatitis 21 Case A 35-year-old man presented with large plaques on his elbows and trunk. 22 23 Psoriasis Psoriasis vulgaris • Clinical • Usually presents in 2nd-3rd decades • Erythematous plaques with silvery scale • Extensor surfaces, scalp, gluteal cleft, glans penis • Nail pitting and yellow discoloration • Arthritis 1-5% Psoriasis Vulgaris • Microscopic • Uniform acanthosis with elongated rete ridges • Absent (diminished) granular layer • Prominent parakeratosis • Neutrophils in stratum corneum (Munro‘s microabscess) and/or epidermis (pustules of Kogoj) • Suprapapillary plate thinning • Dilated, tortuous papillary dermal vessels 24 Psoriasis Vulgaris • Differential Diagnosis • Nummular dermatitis • Contact dermatitis • Seborrheic dermatitis • Pityriasis rubra pilaris • Dermatophytosis Psoriasis Vulgaris • Practical tips • Eosinophils absent in psoriasis (intravascular eosinophils don‘t count) with one exception • Epidermal hyperplasia not always uniform • Impetiginization not seen • May see some granular layer in rubbed psoriasis • Some features may be absent in partially treated psoriasis • Descriptive dx: psoriasiform dermatitis 25 Psoriasis Variants Pustular psoriasis • Clinical • Associated with pregnancy and discontinuation of systemic steroids • Rapid onset • Microscopic • Epidermal hyperplasia rare • Granular layer diminished but not absent • Large neutrophilic abscesses in epidermis and stratum corneum • Little spongiosis • Differential Diagnosis • candidiasis, eczematous dermatitis with secondary impetiginization, acute generalized exanthematous pustulosis (AGEP), IgA pemphigus http://www.internationaleczema-psoriasisfoundation.org 26 Psoriasis Variants Guttate psoriasis • Clinical • Rapid onset • Widespread disease • Small scaly plaques • Antecedent streptococcal infection 27 Psoriasis Guttate psoriasis • Microscopic • Minimal acanthosis • Diminished granular layer (variable) • Focal mounds of parakeratosis with neutrophils • Differential Diagnosis • Pityriasis rosea TNF-α Inhibitor-induced psoriasis • TNF-α inhibitors • Examples: infliximab, adalimumab, certolizumab • Used to treat inflammatory bowel disease, rheumatoid arthritis, psoriasis • Can induce psoriasis • Histologically resembles psoriasis vulgaris,
Load more

Recommended publications
  • Paraneoplastic Syndrome Presenting As Giant Porokeratosis in a Patient with Nasopharyngeal Cancer
    Paraneoplastic Syndrome Presenting As Giant Porokeratosis in A Patient with Nasopharyngeal Cancer Fitri Azizah, Sonia Hanifati, Sri Adi Sularsito, Lili Legiawati, Shannaz Nadia Yusharyahya, Rahadi Rihatmadja Department of Dermatology and Venereology, Faculty of Medicine Universitas Indonesia / Dr. Cipto Mangunkusumo National General Hospital Keywords: porokeratosis, giant porokeratosis, paraneoplastic syndrome, nasopharyngeal Abstract: Giant porokeratosis is a rare condition in which the hyperkeratotic plaques of porokeratosis reach up to 20 cm in diameter. Porokeratosis is characterized clinically by hyperkeratotic papules or plaques with a thread-like elevated border. Although rare, porokeratosis has been reported in conjunction with malignancies suggesting a paraneoplastic nature. Associated malignancies reported were hematopoietic, hepatocellular, and cholangiocarcinoma. We report a case of giant porokeratosis in a patient with nasopharyngeal cancer responding to removal of the primary cancer by chemoradiotherapy. 1 INTRODUCTION regress completely after the treatment of malignancy, suggestive of paraneoplastic syndrome. Porokeratosis is a chronic progressive disorder of keratinization, characterized by hyperkeratotic papules or plaques surrounded by a thread-like 2 CASE elevated border corresponds to a typical histologic hallmark, the cornoid lamella . O regan, 2012) There Mr. SS, 68-year-old, was referred for evaluation of are at least six clinical variants of porokeratosis pruritic, slightly erythematous plaques with raised, recognized with known genetic disorder.1 Some hyperpigmented border of one and a half year clinical variant of porokeratosis has been reported in duration on the extensor surface of both legs. The the setting of immunosuppressive conditions, organ lesions shown minimal response to potent topical transplantation, use of systemic corticosteroids, and corticosteroids and phototherapy given during the infections, suggesting that impaired immunity may last 8 months in another hospital.
    [Show full text]
  • Inflammatory Skin Disease Every Pathologist Should Know
    Inflammatory skin disease every pathologist should know Steven D. Billings Cleveland Clinic [email protected] General Concepts • Pattern recognition – Epidermal predominant vs. dermal predominant • Epidermal changes trump dermal changes – Distribution of the inflammatory infiltrate • Superficial vs. superficial and deep • Location: perivascular, interstitial, nodular – Nature of inflammatory infiltrate • Mononuclear (lymphocytes and histiocytes) • Mixed (mononuclear and granulocytes) • Granulocytic • Correlation with clinical presentation • Never diagnose “chronic nonspecific dermatitis” Principle Patterns: Epidermal Changes Predominant • Spongiotic pattern • Psoriasiform pattern – Spongiotic and psoriasiform often co-exist • Interface pattern – Basal vacuolization • Perivascular infiltrate or • Lichenoid infiltrate Principle Patterns: Dermal Changes Predominant • Superficial perivascular • Superficial and deep perivascular • Interstitial pattern – Palisading granulomatous – Nodular and diffuse • Sclerosing pattern • Panniculitis • Bullous disease • Miscellaneous Spongiotic Dermatitis • Three phases – Acute – Subacute – Chronic • Different but overlapping histologic features Spongiotic Dermatitis • Acute spongiotic dermatitis – Normal “basket-weave” stratum corneum – Pale keratinocytes – Spongiosis – Spongiotic vesicles (variable) – Papillary dermal edema – Variable superficial perivascular infiltrate of lymphocytes often with some eosinophils – Rarely biopsied in acute phase Spongiotic Dermatitis • Subacute spongiotic dermatitis – Parakeratosis
    [Show full text]
  • Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: Specific Drugs
    Specific Drugs Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: Specific Drugs Chief Editors: Ana Dioun Broyles, MD, Aleena Banerji, MD, and Mariana Castells, MD, PhD Ana Dioun Broyles, MDa, Aleena Banerji, MDb, Sara Barmettler, MDc, Catherine M. Biggs, MDd, Kimberly Blumenthal, MDe, Patrick J. Brennan, MD, PhDf, Rebecca G. Breslow, MDg, Knut Brockow, MDh, Kathleen M. Buchheit, MDi, Katherine N. Cahill, MDj, Josefina Cernadas, MD, iPhDk, Anca Mirela Chiriac, MDl, Elena Crestani, MD, MSm, Pascal Demoly, MD, PhDn, Pascale Dewachter, MD, PhDo, Meredith Dilley, MDp, Jocelyn R. Farmer, MD, PhDq, Dinah Foer, MDr, Ari J. Fried, MDs, Sarah L. Garon, MDt, Matthew P. Giannetti, MDu, David L. Hepner, MD, MPHv, David I. Hong, MDw, Joyce T. Hsu, MDx, Parul H. Kothari, MDy, Timothy Kyin, MDz, Timothy Lax, MDaa, Min Jung Lee, MDbb, Kathleen Lee-Sarwar, MD, MScc, Anne Liu, MDdd, Stephanie Logsdon, MDee, Margee Louisias, MD, MPHff, Andrew MacGinnitie, MD, PhDgg, Michelle Maciag, MDhh, Samantha Minnicozzi, MDii, Allison E. Norton, MDjj, Iris M. Otani, MDkk, Miguel Park, MDll, Sarita Patil, MDmm, Elizabeth J. Phillips, MDnn, Matthieu Picard, MDoo, Craig D. Platt, MD, PhDpp, Rima Rachid, MDqq, Tito Rodriguez, MDrr, Antonino Romano, MDss, Cosby A. Stone, Jr., MD, MPHtt, Maria Jose Torres, MD, PhDuu, Miriam Verdú,MDvv, Alberta L. Wang, MDww, Paige Wickner, MDxx, Anna R. Wolfson, MDyy, Johnson T. Wong, MDzz, Christina Yee, MD, PhDaaa, Joseph Zhou, MD, PhDbbb, and Mariana Castells, MD, PhDccc Boston, Mass; Vancouver and Montreal,
    [Show full text]
  • The Prevalence of Paediatric Skin Conditions at a Dermatology Clinic
    RESEARCH The prevalence of paediatric skin conditions at a dermatology clinic in KwaZulu-Natal Province over a 3-month period O S Katibi,1,2 MBBS, FMCPaed, MMedSci; N C Dlova,2 MB ChB, FCDerm, PhD; A V Chateau,2 BSc, MB ChB, DCH, FCDerm, MMedSci; A Mosam,2 MB ChB, FCDerm, MMed, PhD 1 Dermatology Unit, Department of Paediatrics and Child Health, University of Ilorin, Kwara State, Nigeria 2 Department of Dermatology, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa Corresponding author: O S Katibi ([email protected]) Background. Skin conditions are common in children, and studying their spectrum in a tertiary dermatology clinic will assist in quantifying skin diseases associated with greatest burden. Objective. To investigate the spectrum and characteristics of paediatric skin disorders referred to a tertiary dermatology clinic in Durban, KwaZulu-Natal (KZN) Province, South Africa. Methods. A cross-sectional study of children attending the dermatology clinic at King Edward VIII Hospital, KZN, was carried out over 3 months. Relevant demographic information and clinical history pertaining to the skin conditions were recorded and diagnoses were made by specialist dermatologists. Data were analysed with EPI Info 2007 (USA). Results. There were 419 children included in the study; 222 (53%) were males and 197 (47%) were females. A total of 64 diagnosed skin conditions were classified into 16 categories. The most prevalent conditions by category were dermatitis (67.8%), infections (16.7%) and pigmentary disorders (5.5%). For the specific skin diseases, 60.1% were atopic dermatitis (AD), 7.2% were viral warts, 6% seborrhoeic dermatitis and 4.1% vitiligo.
    [Show full text]
  • 86A1bedb377096cf412d7e5f593
    Contents Gray..................................................................................... Section: Introduction and Diagnosis 1 Introduction to Skin Biology ̈ 1 2 Dermatologic Diagnosis ̈ 16 3 Other Diagnostic Methods ̈ 39 .....................................................................................Blue Section: Dermatologic Diseases 4 Viral Diseases ̈ 53 5 Bacterial Diseases ̈ 73 6 Fungal Diseases ̈ 106 7 Other Infectious Diseases ̈ 122 8 Sexually Transmitted Diseases ̈ 134 9 HIV Infection and AIDS ̈ 155 10 Allergic Diseases ̈ 166 11 Drug Reactions ̈ 179 12 Dermatitis ̈ 190 13 Collagen–Vascular Disorders ̈ 203 14 Autoimmune Bullous Diseases ̈ 229 15 Purpura and Vasculitis ̈ 245 16 Papulosquamous Disorders ̈ 262 17 Granulomatous and Necrobiotic Disorders ̈ 290 18 Dermatoses Caused by Physical and Chemical Agents ̈ 295 19 Metabolic Diseases ̈ 310 20 Pruritus and Prurigo ̈ 328 21 Genodermatoses ̈ 332 22 Disorders of Pigmentation ̈ 371 23 Melanocytic Tumors ̈ 384 24 Cysts and Epidermal Tumors ̈ 407 25 Adnexal Tumors ̈ 424 26 Soft Tissue Tumors ̈ 438 27 Other Cutaneous Tumors ̈ 465 28 Cutaneous Lymphomas and Leukemia ̈ 471 29 Paraneoplastic Disorders ̈ 485 30 Diseases of the Lips and Oral Mucosa ̈ 489 31 Diseases of the Hairs and Scalp ̈ 495 32 Diseases of the Nails ̈ 518 33 Disorders of Sweat Glands ̈ 528 34 Diseases of Sebaceous Glands ̈ 530 35 Diseases of Subcutaneous Fat ̈ 538 36 Anogenital Diseases ̈ 543 37 Phlebology ̈ 552 38 Occupational Dermatoses ̈ 565 39 Skin Diseases in Different Age Groups ̈ 569 40 Psychodermatology
    [Show full text]
  • Pemphigus and Other Bullous Dermatoses: Correlation of Clinical and Pathologic Findings
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector PEMPHIG[JS AND OTHER BULLOUS DERMATOSES: CORRELATION OF CLINICAL AND PATHOLOGIC FINDINGS" JOSEPH G. BRENNAN, M.D.t AND HAMILTON MONTGOMERY, M.D4 A detailed clinical and histopathologic study has been made of patients who had pemphigus of various types and of patients who had other bullous derma- toses; this study includes follow-up information covering a period of years. The lesions in some of these patients have had to he reclassified on the basis of newer histologic concepts of pemphigus, namely the phenomenon of acantholysis, which is seen in pemphigus and not in other bullous dermatoses, except for those caused by viral diseases. By acantholysis is meant loss of prickles of the prickle cells in the epidermis, with lysis of the individual cell. This phenomenon, occurring as a primary change in pemphigus in distinction from pressure or tension phenomena, which are the primary changes in other bullous dermatoses (except for pemphi- gus and viral diseases), is considered in another article by one of us (Brennan, 1). Differentiation of bullous dermatoses was accepted clinically prior to 1848, when Simon (2) considered that the bulla of pemphigus could be differentiated histologically because it was subepidermal and because the hair follicle was torn off. Haight (3), in 1868, thought the bulla of pemphigus was under the stratum corneum and was characterized by fissures formed by long, drawn-out prickle cells. Auspitz (4), in 1881, classified bullous dermatoses accord- ing to their histology and was the first to describe acantholysis.
    [Show full text]
  • 2. Studies of Cancer in Humans
    P_179_278.qxp 30/11/2007 09:40 Page 179 HUMAN PAPILLOMAVIRUSES 179 2. Studies of Cancer in Humans 2.1 Methodological concerns (a) Choice of disease end-point To obtain epidemiological evidence of the risk for cervical cancer due to a specific type of human papillomavirus (HPV), the choice of disease end-point must be appro- priate. The risk for invasive cancer is examined optimally by a case–control design or among historical cohorts in which archived specimens are tested. Prospective studies that follow women forward in time must ethically rely on surro- gate end-points, the choice of which is critical. For studies of HPV infection, invasive cancer and grade 3 cervical intraepithelial neoplasia (CIN3; which subsumes diagnoses of severe dysplasia and carcinoma in situ) are considered to be the primary disease end- points. The inclusion of CIN3 as a surrogate for invasive cancer permits prospective studies that would otherwise be unethical, because it is a condition that often requires medical treatment, whith thus interrupts the natural history of the disease. CIN3 is the immediate precursor of invasive cervical cancer, and the two diseases share a similar P_179_278.qxp 30/11/2007 09:40 Page 180 180 IARC MONOGRAPHS VOLUME 90 cross-sectional virological and epidemiological profile (except for an earlier average age at diagnosis of CIN3) and demonstrate good histopathological reproducibility (Shah et al., 1980; Walker et al., 1983; Muñoz et al., 1992, 1993). Therefore, CIN3 is a practical surro- gate end-point for cervical cancer, although a proportion of cases of CIN3 regress rather than invade. However, in cohort studies, new diagnoses of small CIN3 lesions may repre- sent diseases that were missed at the time of enrolment when HPV was assayed.
    [Show full text]
  • Pigmented Actinic Keratosis: Case Report and Review of an Uncommon Actinic Keratosis Variant That Can Mimic Melanoma
    Open Access Case Report DOI: 10.7759/cureus.4721 Pigmented Actinic Keratosis: Case Report and Review of an Uncommon Actinic Keratosis Variant that can Mimic Melanoma Boya Abudu 1 , Antoanella Calame 2 , Philip R. Cohen 3 1. Internal Medicine, Kaiser Permanente Oakland Medical Center, Oakland, USA 2. Dermatology, Compass Dermatopathology, Inc., San Diego, USA 3. Dermatology, San Diego Family Dermatology, National City, USA Corresponding author: Boya Abudu, [email protected] Abstract Pigmented actinic keratosis is an uncommon variant of actinic keratosis that can mimic melanocytic lesions. A 54-year-old man who presented with a dark lesion on his nasal tip is described; biopsy of the lesion revealed a pigmented actinic keratosis that was treated with cryotherapy using liquid nitrogen. Pigmented actinic keratoses typically appear on sun-exposed areas of the skin as flat hyperpigmented lesions that grow in a centrifugal pattern. Dermoscopy reveals one or more pseudonetworks with hyperpigmented dots or globules. Histopathology shows atypical keratinocytes in the epidermal basal layer and increased melanin content in the epidermis and dermis. Treatment options include liquid nitrogen cryotherapy for solitary lesions and curettage, 5-fluorouracil, imiquimod, ingenol mebutate, photodynamic therapy, or superficial peels for extensive lesions. Categories: Dermatology, Pathology Keywords: actinic, immunoperoxidase, keratosis, lentigo, maligna, malignant, melanoma, pigmented, solar, spreading Introduction Pigmented actinic keratosis is an uncommon clinical variant of actinic keratosis [1-18]. This precancerous lesion can mimic not only melanocytic lesions but also other epithelial tumors [7-8,16-18]. The clinical and pathologic features of an actinic keratosis on the nasal tip of a man are described and the characteristics of this unique lesion are reviewed.
    [Show full text]
  • Dermatologic Practice Review of Common Skin Diseases in Nigeria
    International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Review Article Dermatologic Practice Review of Common Skin Diseases in Nigeria Eshan Henshaw1, Perpetua Ibekwe2, Adedayo Adeyemi3, Soter Ameh4, Evelyn Ogedegbe5, Joseph Archibong1, Olayinka Olasode6 1Department of Internal Medicine, 4Department of Community Medicine, University of Calabar, Calabar, Nigeria 2University of Abuja Teaching Hospital, Gwagwalada, 3Center for Infectious Diseases Research and Evaluation, 5Cedarcrest Hospitals Abuja, Abuja Nigeria 6Department of Dermatology, Obafemi Awolowo University, Ile-Ife, Osun State, Nigeria Corresponding Author: Eshan Henshaw ABSTRACT Objective: Dermatology is a relatively novel medical specialty in Nigeria, requiring a needs assessment to ensure optimal provision of dermatologic care to the general public. While several authors have catalogued the pattern of skin diseases in their respective regions of practice, none can be said to provide a panoramic representation of the general pattern in Nigeria. This article reviews and synthesizes findings from existing studies on the pattern of skin diseases in Nigeria published from January 2000 to December 2016, with the aim of presenting a unified data on the common dermatoses in Nigeria. Methods: Electronic and hand searches of articles reporting on the general pattern of skin diseases in Nigeria, published between the years 2000 and 2016 was performed. Eleven articles met the criteria for inclusion, two of which were merged into one, as they were products of a single survey. Thus ten studies were systematically reviewed and analysed. Results: A cumulative total of 16,151 patients were seen, among which one hundred and twenty two (122) specific diagnoses were assessed. The ten leading dermatoses in descending order of relative frequencies were: atopic dermatitis, tinea, acne, contact dermatitis, urticaria, seborrheic dermatitis, pityriasis versicolor, vitiligo, human papilloma virus infections, and adverse cutaneous drug reactions.
    [Show full text]
  • The Best Diagnosis Is: A
    DERMATOPATHOLOGY DIAGNOSIS H&E, original magnification ×40. The best diagnosis is: a. lichen striatus copy b. linear epidermolytic hyperkeratosis c. linear lichen planus d. linear porokeratosisnot e. linear psoriasis Do A H&E, original magnification ×CUTIS40. B H&E, original magnification ×200 for both. PLEASE TURN TO PAGE 120 FOR DERMATOPATHOLOGY DIAGNOSIS DISCUSSION Jacqueline N. Graham, BS; Eric W. Hossler, MD Ms. Graham is from Northeast Ohio Medical University, Rootstown. Dr. Hossler is from the Departments of Dermatology and Pathology, Geisinger Medical Center, Danville, Pennsylvania. The authors report no conflict of interest. Correspondence: Jacqueline N. Graham, BS, 4249 Pine Dr, Rootstown, OH 44272 ([email protected]). 86 CUTIS® WWW.CUTIS.COM Copyright Cutis 2015. No part of this publication may be reproduced, stored, or transmitted without the prior written permission of the Publisher. Dermatopathology Diagnosis Discussion Lichen Striatus ichen striatus (LS) is a benign, uncommon, self-limited, linear inflammatory skin disorder Lthat primarily affects children up to 15 years of age, most commonly around 2 to 3 years of age, and is seen more frequently in girls.1 It presents with a sudden eruption of asymptomatic small, flat- topped, lichenoid, scaly papules in a linear array on a single extremity. The lesions may be erythematous, flesh colored, or hypopigmented.1,2 Multiple lesions appear over days to weeks and coalesce into linear plaques in a continuous or interrupted pattern along the lines of Blaschko, indicating possible
    [Show full text]
  • Adalimumab Injection
    PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION PrHUMIRA® adalimumab injection 40 mg in 0.8 mL sterile solution (50 mg/mL) subcutaneous injection 10 mg in 0.1 mL sterile solution (100 mg/mL) subcutaneous injection 20 mg in 0.2 mL sterile solution (100 mg/mL) subcutaneous injection 40 mg in 0.4 mL sterile solution (100 mg/mL) subcutaneous injection 80 mg in 0.8 mL sterile solution (100 mg/mL) subcutaneous injection Biological Response Modifier Humira (adalimumab injection) treatment should be initiated and supervised by specialist physicians experienced in the diagnosis and treatment of rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, adult and pediatric (13 to 17 years of age weighing ≥ 40 kg) Crohn’s disease, adult and pediatric (5 to 17 years of age) ulcerative colitis, adult and adolescent (12 to 17 years of age weighing ≥ 30 kg) hidradenitis suppurativa, psoriasis or adult and pediatric uveitis, and familiar with the Humira efficacy and safety profile. Date of Initial Approval: September 24, 2004 Date of Previous Revision: March 19, 2021 AbbVie Corporation Date of Revision: 8401 Trans-Canada Highway April 21, 2021 St-Laurent, QC H4S 1Z1 Submission Control No: 239280 HUMIRA Product Monograph Page 1 of 192 Date of Revision: April 21, 2021 and Control No. 239280 RECENT MAJOR LABEL CHANGES Dosage and Administration, Recommended Dose and Dosage Adjustment (4.2) 06/2019 TABLE OF CONTENTS PART I: HEALTH PROFESSIONAL INFORMATION ..................................................................
    [Show full text]
  • Pathology.Pre-Test.Pdf
    Pathology PreTestTMSelf-Assessment and Review Notice Medicine is an ever-changing science. As new research and clinical experience broaden our knowledge, changes in treatment and drug therapy are required. The authors and the publisher of this work have checked with sources believed to be reliable in their efforts to provide information that is complete and generally in accord with the standards accepted at the time of publication. However, in view of the possibility of human error or changes in medical sciences, neither the authors nor the publisher nor any other party who has been involved in the preparation or publication of this work warrants that the information contained herein is in every respect accurate or complete, and they disclaim all responsibility for any errors or omissions or for the results obtained from use of the information contained in this work. Readers are encouraged to confirm the information contained herein with other sources. For example, and in particular, readers are advised to check the product information sheet included in the package of each drug they plan to administer to be certain that the information contained in this work is accurate and that changes have not been made in the recommended dose or in the contraindications for administration. This recommendation is of particular importance in connection with new or infrequently used drugs. Pathology PreTestTMSelf-Assessment and Review Twelfth Edition Earl J. Brown, MD Associate Professor Department of Pathology Quillen College of Medicine Johnson City, Tennessee New York Chicago San Francisco Lisbon London Madrid Mexico City Milan New Delhi San Juan Seoul Singapore Sydney Toronto Copyright © 2007 by The McGraw-Hill Companies, Inc.
    [Show full text]